Twelve-month results of percutaneous endovascular reconstruction for chronically occluded superficial femoral arteries: A quality-of-life assessment

Journal of Invasive Cardiology

Volumn 18, Issue 7, 2006, Pages 316-321

  Dippel, Eric ^a,b   Shammas, Nicolas ^b   Takes, Vickie ^c   Coyne, Lauren ^c   Lemke, Jon ^c  

^a Cardiovascular Medicine Davenport   (United States)

^b MIDWEST CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c Genesis Heart Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBIN; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; NITINOL;

ADULT; AGED; ANGIOPLASTY; ANKLE BRACHIAL INDEX; ARTERY OCCLUSION; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CHRONIC TOTAL OCCLUSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CORONARY STENT; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HUMAN; LEG REVASCULARIZATION; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; QUESTIONNAIRE; RHEOLYTIC THROMBECTOMY; SUPERFICIAL FEMORAL ARTERY; SURGICAL TECHNIQUE; THROMBOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; WALKING IMPAIRMENT QUESTIONNAIRE;

AGED; ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; FEMORAL ARTERY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOBILITY LIMITATION; PERIPHERAL VASCULAR DISEASES; QUALITY OF LIFE; QUESTIONNAIRES; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 33745742741     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Criqui MH, Deneberg JO, Langer RD, et al. The epidemiology of peripheral arterial disease: Importance of identifying population at risk. Vasc Med 1997;2:221-226.
2. Kannel WB, Skinner JJ, Schwartz MJ, et al. Intermittent claudication: Incidence in the Framingham Study. Circulation 1970;16:875-883.
3. Dormandy JA, Rutherford RB. Management of peripheral arterial disease. TransAtlantic InterSociety Consensus (TASC). J Vasc Surg 2000;31(Suppl; 1 pt 2):1-296.
4. Newman AB, Sutton-Tyrell K, Vogt MT, et al. Morbidity and mortality in hypertensive adults with low ankle/arm blood pressure index. JAMA 1993;270:487-489.
5. Hirsch AT, Criqui MH, Treat-Jacobsen D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-1324.
6. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991;87:119-128.
7. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-386.
8. Adapted from Understanding Health Outcomes Educational Series, 1998.
9. Management of Peripheral Arterial Disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000;31(Suppl):S1- S296.
10. Hiatt WR, Hirsch AT, Regensteiner JG, et al. Clinical trials for claudication: Assessment of exercise performance, functional status, and clinical endpoints. Circulation 1995;92:614-621.
11. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
12. Kiemeneij F, Serruys PW, Macaya C, et al. Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of BENESTENT-I trial. J Am Coll Cardiol 2001;37:1598-1603.
13. Sirnes PA, Golf S, Myreng Y, et al. Sustained benefit of stenting chronic coronary occlusion: Long-term clinical follow-up of the Stenting In Chronic Coronary Occlusion (SICCO) study. J Am Coll Cardiol 1998;32:305-310.
14. Rubartelli P, Verna E, Niccoli L, et al. Coronary stent Implantation is superior to balloon angioplasty for chronic coronary occlusions: Six-year clinical follow-up of the GISSOC trial. J Am Coll Cardiol 2003;41:1488-1492 .
15. Stanley B, Teague B, Raptis S, et al. Efficacy of balloon angioplasty of the superficial femoral artery and popliteal artery in the relief of leg ischemia. J Vasc Surg 1996;23:679-685.
16. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery Disease after suboptimal angioplasty. J Vasc Surg 1997;25:74-83.
17. Gray BH, Olin JW. Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease. Semin Vasc Surg 1997;10:8-16.
18. Hayerizadeh BF, Zeller T, Krankenberg H, et al. Superficial femoral artery stenting using nitinol stents - A German multicenter experience. J Invasive Cardiol 2004;16(Suppl A):12A-14A.
19. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-month results of the SIROCCO study. Circulation 2002;106:1505-1509.
20. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: A prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000;32:268-277.
21. Green RM, Abbott WM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: Five-year results of a randomized trial. J Vasc Surg 2000;31:417-425.